These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3611108)

  • 21. Inactivation of human coagulation factor V by activated protein C.
    Suzuki K; Stenflo J; Dahlbäck B; Teodorsson B
    J Biol Chem; 1983 Feb; 258(3):1914-20. PubMed ID: 6687387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural requirements for expression of factor Va activity.
    Kalafatis M; Beck DO; Mann KG
    J Biol Chem; 2003 Aug; 278(35):33550-61. PubMed ID: 12788947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of factor Va and factor VIIIa by activated platelets.
    Kalafatis M; Rand MD; Jenny RJ; Ehrlich YH; Mann KG
    Blood; 1993 Feb; 81(3):704-19. PubMed ID: 8427963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of coagulation factor Xa and des-(1-44)factor Xa in the assembly of prothrombinase.
    Skogen WF; Esmon CT; Cox AC
    J Biol Chem; 1984 Feb; 259(4):2306-10. PubMed ID: 6698966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The factor Xa-catalyzed activation of factor V.
    Foster WB; Nesheim ME; Mann KG
    J Biol Chem; 1983 Nov; 258(22):13970-7. PubMed ID: 6643460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va.
    Tracy PB; Mann KG
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2380-4. PubMed ID: 6572981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors.
    Rezaie AR; Esmon CT
    J Biol Chem; 1993 Sep; 268(27):19943-8. PubMed ID: 8104182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations.
    Tracy PB; Eide LL; Mann KG
    J Biol Chem; 1985 Feb; 260(4):2119-24. PubMed ID: 3972783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human protein S cleavage and inactivation by coagulation factor Xa.
    Long GL; Lu D; Xie RL; Kalafatis M
    J Biol Chem; 1998 May; 273(19):11521-6. PubMed ID: 9565566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of complexes and their derivatives formed during inhibition of bovine thrombin and activated factor X by antithrombin III.
    Jesty J
    J Biol Chem; 1979 Feb; 254(4):1044-9. PubMed ID: 762113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional properties of human factor Va lacking the Asp683-Arg709 domain of the heavy chain.
    Bakker HM; Tans G; Thomassen MC; Yukelson LY; Ebberink R; Hemker HC; Rosing J
    J Biol Chem; 1994 Aug; 269(32):20662-7. PubMed ID: 8051166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
    Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
    Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
    Mesters RM; Heeb MJ; Griffin JH
    Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activation of coagulation factor X. Identity of cleavage sites in the alternative activation pathways and characterization of the COOH-terminal peptide.
    Jesty J; Spencer AK; Nakashima Y; Nemerson Y; Konigsberg W
    J Biol Chem; 1975 Jun; 250(12):4497-504. PubMed ID: 1141218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of activated protein C by factor Xa.
    Jane SM; Hau L; Salem HH
    Blood Coagul Fibrinolysis; 1991 Dec; 2(6):723-9. PubMed ID: 1839223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
    J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies selective for activated Factor V. Immunochemical probes for structural transitions occurring during the thrombin-catalyzed activation of the procofactor.
    Foster WB; Tucker MM; Katzmann JA; Mann KG
    J Biol Chem; 1983 May; 258(9):5608-13. PubMed ID: 6853534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of recombinant human factor VIII.
    Eaton DL; Hass PE; Riddle L; Mather J; Wiebe M; Gregory T; Vehar GA
    J Biol Chem; 1987 Mar; 262(7):3285-90. PubMed ID: 3102485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of prothrombin with factor Va-phospholipid complexes.
    van de Waart P; Hemker HC; Lindhout T
    Biochemistry; 1984 Jun; 23(12):2838-42. PubMed ID: 6466619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.